With the interior ministry set to formally roll out licences for industrial and medicinal cannabis, a question over whether oversight should remain under the Narcotics Control Commission and the Ministry of the Interior or transition toward a trade-led framework aligned with commercial expansion is intensifying
The long-overdue licensing regime is expected to be released today by the Ministry of the Interior, providing a detailed fee structure for cultivation, processing and related operations. Market participants indicate that proposed licence fees could range from $5,000 to $42,000 depending on the category of activity. The sector operates under a strict legal framework limiting production to industrial hemp with tetrahydrocannabinol levels capped at 0.3% (with no “high” effect), confined to medical and industrial use. Recreational cannabis remains prohibited.
While the narcotics commission’s supervision reflects the plant’s historical classification as a controlled substance, retaining the sector under a law-enforcement umbrella could create reputational headwinds as Ghana positions cannabis as an export-oriented agribusiness and pharmaceutical trade.
Global investors typically assess regulatory alignment, institutional clarity and ministerial positioning when evaluating new industries. Placement under a security-focused body may influence perceptions of risk, compliance costs and long-term policy stability. Keeping the industry within the Interior Ministry’s regulatory orbit also strengthens traceability, compliance and adherence to international drug control conventions during the sector’s formative stage. But is that not likely to stifle its growth as it may continued to be perceive more as a narcotic substance rather than a business, as market watchers have questioned.
The pending licence announcement is viewed as a critical milestone for investors who have delayed capital commitments pending clarity on entry costs and regulatory processes. The level at which fees are ultimately set will also shape participation, determining whether the industry broadens to include small and medium-scale operators or tilts toward well-capitalised firms.
Beyond licensing, the broader question is how Ghana intends to frame the industry’s identity? As an extension of narcotics control policy or as a new pillar of agro-processing, pharmaceuticals and export manufacturing, under the Ministry of Trade, Agribusiness and Industry?
The answer could influence foreign direct investment flows, access to international finance and the speed at which industrial cannabis integrates into the country’s wider trade and industrial strategy.
